Ideomed Moves Abriiz System To Amazon Web Services
GRAND RAPIDS (WWJ) -- Grand Rapids-based Ideomed Inc. announced Wednesday that its flagship system Abriiz is migrating to Amazon Web Services.
Abriiz is a web and mobile based solution that helps people manage chronic medical conditions such as asthma, diabetes and heart disease. Abriiz also supports those who just want to get and stay healthy, by encouraging positive lifestyle choices.
Ideomed says the highly customizable platform is designed to help anyone - from pregnant mothers and their developing babies, to teens working on weight issues, and those with multiple chronic illnesses.
Ideomed's "Care Team Connected" approach links patients with family members, physicians, and care managers, creating a personalized network of support.
"Our first release of Abriiz targeted children with asthma," said Ideomed CEO Keith Brophy. "While we had high hopes for the positive impact Abriiz could have, our initial results even exceeded our own expectations. For example, in one clinical trial, participant emergency room visits dropped from 12 in the six months before using Abriiz to zero visits while using the tool. Additional trials had similar results, which encouraged us to expand to other chronic illnesses. In addition to asthma, we are now supporting patients ranging in age from 7 to 77 with Heart Disease and Diabetes, and more conditions in development. With over 150,000 medication reminders delivered and climbing every day, we feel confident that Abriiz is improving people's lives."
Added Lisa Schutte, Ideomed vice president of technology: "Moving Abriiz to AWS allows Ideomed to better achieve our core goal of improving people's lives with the assurance that their privacy and security are completely protected ... After all, we're the stewards of our patients' most personal information, we have an obligation to keep it safe and AWS is key to that commitment."
Ideomed adopted AWS with the help of Royal Oak-based Cloudticity, an AWS consulting partner. More at www.cloudticity.com.
Ideomed markets and sells Abriiz to insurers, managed Medicaid providers, and health systems for delivery to their patient populations. For more information, visit www.ideomed.com.
